Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Study of Selonsertib in Bridging Fibrosis Study Does Not Meet Primary Endpoint

americanpharmaceuticalreviewApril 26, 2019

Tag: Selonsertib , Bridging Fibrosis Study , STELLAR-3

PharmaSources Customer Service